04/18/2024
3:56 PM | TG Therapeutics (Filer)
| Form PRE 14A | |
03/15/2024
3:37 PM | Lonial Sagar (Reporting)
TG Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:52 PM | Charney Laurence N (Reporting)
TG Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:10 PM | Lonial Sagar (Reporting)
TG Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2024
10:24 AM | Charney Laurence N (Reporting)
TG Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
4:23 PM | TG Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/28/2024
6:24 AM | TG Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
02/14/2024
8:53 PM | Power Sean A (Reporting)
TG Therapeutics (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/14/2024
2:30 PM | Darwin Global Management, Ltd. (Filed by)
TG Therapeutics (Subject)
| Form SC 13G/A | |
01/25/2024
10:29 AM | STATE STREET CORP (Filed by)
TG Therapeutics (Subject)
| Form SC 13G/A | |
01/10/2024
6:37 AM | TG Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
5:32 PM | TG Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
5:33 PM | Charney Laurence N (Reporting)
TG Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
4:00 PM | Power Sean A (Reporting)
TG Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
10:02 AM | Charney Laurence N (Reporting)
TG Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2023
6:33 AM | TG Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
8:54 AM | TG Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/04/2023
3:30 PM | TG Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2023
6:29 AM | TG Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2023
4:00 PM | Lonial Sagar (Reporting)
TG Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:25 PM | Lonial Sagar (Reporting)
TG Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023
5:26 PM | Power Sean A (Reporting)
TG Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2023
6:59 AM | TG Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/01/2023
3:17 PM | TG Therapeutics (Filer)
| Form DEF 14A | |
05/01/2023
3:19 PM | TG Therapeutics (Filer)
| Form DEFA14A | |
05/01/2023
6:35 AM | TG Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
